GENESCAPE Trademark

Trademark Overview


On Thursday, April 21, 2022, a trademark application was filed for GENESCAPE with the United States Patent and Trademark Office. The USPTO has given the GENESCAPE trademark a serial number of 97373762. The federal status of this trademark filing is REGISTERED as of Tuesday, June 6, 2023. This trademark is owned by Genetic Networks, LLC. The GENESCAPE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; scientific and technological services, namely scientific research and analysis in the field of target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small molecules, proteins, RNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research in the nature of comprehensive analy...
genescape

General Information


Serial Number97373762
Word MarkGENESCAPE
Filing DateThursday, April 21, 2022
Status700 - REGISTERED
Status DateTuesday, June 6, 2023
Registration Number7072995
Registration DateTuesday, June 6, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and ServicesDrug discovery services; scientific and technological services, namely scientific research and analysis in the field of target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small molecules, proteins, RNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research in the nature of comprehensive analysis of competitive drugs and derivatives thereof from a functional genome response to find new drug targets

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2023
Primary Code042
First Use Anywhere DateMonday, April 27, 2020
First Use In Commerce DateSunday, June 6, 2021

Trademark Owner History


Party NameGenetic Networks, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33136

Party NameGenetic Networks, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33136

Party NameGenetic Networks, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33136

Trademark Events


Event DateEvent Description
Tuesday, June 6, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 6, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, February 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 15, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, February 15, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 8, 2023ASSIGNED TO EXAMINER
Wednesday, April 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 25, 2022NEW APPLICATION ENTERED